Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06924801 · ClinicalTrials.gov registry record · NA
Integration of Real-Time Motion Tracking and Pediatric Rehabilitation
A NA study of Rehabilitation, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06924801: Recruiting NA study of Rehabilitation, sponsored by Stanford University.
NCT06924801 is a NA study of Rehabilitation that is actively recruiting participants, run by Stanford University. The registered enrollment target is 30 participants, below the 163-participant average among 15 other Rehabilitation trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06924801, a NA study of Rehabilitation, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.
Primary Outcome
10-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to measure usability.
Conditions Studied
Interventions
- BEHAVIORAL Snipperfingers
Study Locations (1)
California
- Lucile Packard Children's Hospital Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT06924801 shows while recruiting
NCT06924801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 163-participant average among 15 other Rehabilitation trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Snipperfingers is the first listed.
NCT06924801 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06924801 about?
NCT06924801 is a clinical study titled "Integration of Real-Time Motion Tracking and Pediatric Rehabilitation". Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can co...
What is the current status of trial NCT06924801?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-15. Estimated completion is 2026-09-30.
What conditions does trial NCT06924801 study?
This clinical trial studies the following conditions: Rehabilitation.
What interventions are being tested in trial NCT06924801?
The interventions under investigation include: Snipperfingers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06924801?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06924801 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06924801's enrollment target sits among peer trials
30 13th of 15 higher than 2 of 15 other Rehabilitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rehabilitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spinal Cord Stimulation and Respiration After Injury
RECRUITING · NA
-
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation
RECRUITING · NA
-
Sex-specific Determinants of Early-phase Recovery From Skeletal Muscle Disuse
RECRUITING · NA
-
Brain Injury Education and Outpatient Navigation-1stBIEN
RECRUITING · NA
-
Skilled Nursing Facility at Home Trial
RECRUITING · NA
-
Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI